As antibody-drug conjugates become more sophisticated, understanding their behavior requires more than a single analytical perspective. DAR characterization, multi-analyte PK, immunogenicity assessment and intact mass spectrometry are becoming increasingly important for teams working to generate robust development insight from complex ADC candidates.
On 22 April 2026 at 2:00 PM CET, Quinta-Analytica, a Conscio Group company, invites you to join a focused expert webinar organised together with SigutLabs:
ADC Performance by Design: From Linker Chemistry to DAR and Bioanalytical Insight
The session will connect upstream chemistry decisions with downstream analytical and bioanalytical interpretation. Topics will include linker design, conjugation strategy, DAR control, conjugate stability, multi-analyte PK, immunogenicity and high-resolution mass spectrometry for intact ADC analysis.
Program highlights:
- The Organic Chemist’s Role in Enhancing ADC Performance
Speaker: Alessandro Panattoni, Head of Chemistry, SigutLabs - Navigating the Complexity of ADCs: Integrated Analytical and Bioanalytical Strategies for Next-Generation Biotherapeutics
Speaker: Milan Maděra, Head of Biologics Department, Conscio Group - Opening remarks & ADC market insights
Host: Jiří Raška, CCO, Conscio Group/Quinta-Analytica
Whether you work in bioanalysis, analytical development, CMC or cross-functional ADC programs, this webinar will offer practical insight into the decisions that influence candidate quality, development readiness and translational understanding. The session includes a live Q&A, giving participants the opportunity to engage directly with the speakers.
